These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34747724)

  • 1. Sexual, physical, and overall adverse effects in patients treated with 5α-reductase inhibitors: a systematic review and meta-analysis.
    Zhang JJ; Shi X; Wu T; Zhang MD; Tang J; Yin GM; Long Z; He LY; Qi L; Wang L
    Asian J Androl; 2022; 24(4):390-397. PubMed ID: 34747724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials.
    Liu L; Zhao S; Li F; Li E; Kang R; Luo L; Luo J; Wan S; Zhao Z
    J Sex Med; 2016 Sep; 13(9):1297-1310. PubMed ID: 27475241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis.
    Corona G; Tirabassi G; Santi D; Maseroli E; Gacci M; Dicuio M; Sforza A; Mannucci E; Maggi M
    Andrology; 2017 Jul; 5(4):671-678. PubMed ID: 28453908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 5-alpha reductase inhibitors: new insights on benefits and harms.
    Lee JY; Cho KS
    Curr Opin Urol; 2018 May; 28(3):288-293. PubMed ID: 29528971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between 5-Alpha Reductase Inhibitor Use and The Risk of Depression: A Meta-Analysis.
    Deng T; Duan X; He Z; Zhao Z; Zeng G
    Urol J; 2020 Aug; 18(2):144-150. PubMed ID: 32869255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia.
    Fang Q; Chen P; Du N; Nandakumar KS
    Clin Breast Cancer; 2019 Oct; 19(5):e624-e636. PubMed ID: 31126837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know?
    Traish AM; Melcangi RC; Bortolato M; Garcia-Segura LM; Zitzmann M
    Rev Endocr Metab Disord; 2015 Sep; 16(3):177-98. PubMed ID: 26296373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of age-related macular degeneration in men receiving 5α-reductase inhibitors: a population-based cohort study.
    Su YC; Shen CY; Shao SC; Lai CC; Hsu SM; Lee CN; Liu CJ; Hung JH; Lai EC
    Age Ageing; 2024 Jul; 53(7):. PubMed ID: 39046116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of a hexanic extract of Serenoa repens (Permixon
    Vela-Navarrete R; Alcaraz A; Rodríguez-Antolín A; Miñana López B; Fernández-Gómez JM; Angulo JC; Castro Díaz D; Romero-Otero J; Brenes FJ; Carballido J; Molero García JM; Fernández-Pro Ledesma A; Cózar Olmos JM; Manasanch Dalmau J; Subirana Cachinero I; Herdman M; Ficarra V
    BJU Int; 2018 Dec; 122(6):1049-1065. PubMed ID: 29694707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis.
    Lee S; Lee YB; Choe SJ; Lee WS
    Acta Derm Venereol; 2019 Jan; 99(1):12-17. PubMed ID: 30206635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-alpha reductase inhibitors and erectile dysfunction: the connection.
    Erdemir F; Harbin A; Hellstrom WJ
    J Sex Med; 2008 Dec; 5(12):2917-24. PubMed ID: 19090946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Effectiveness and Safety of Monodrug Therapies for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Network Meta-analysis.
    Yuan JQ; Mao C; Wong SY; Yang ZY; Fu XH; Dai XY; Tang JL
    Medicine (Baltimore); 2015 Jul; 94(27):e974. PubMed ID: 26166130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review and meta-analysis.
    Gacci M; Ficarra V; Sebastianelli A; Corona G; Serni S; Shariat SF; Maggi M; Zattoni F; Carini M; Novara G
    J Sex Med; 2014 Jun; 11(6):1554-66. PubMed ID: 24708055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-alpha Reductase Inhibitors and risk of male breast cancer: a systematic review and meta-analysis.
    Wang J; Zhao S; Luo L; Li E; Li X; Zhao Z
    Int Braz J Urol; 2018; 44(5):865-873. PubMed ID: 29697934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Jung JH; Kim J; MacDonald R; Reddy B; Kim MH; Dahm P
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012615. PubMed ID: 29161773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of 5α-reductase inhibitors on prostate growth in men receiving testosterone replacement therapy: a systematic review and meta-analysis.
    Cui Y; Zong H; Yang C; Yan H; Zhang Y
    Int Urol Nephrol; 2013 Aug; 45(4):979-87. PubMed ID: 23728850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monotherapy versus combination drug therapy for the treatment of benign prostatic hyperplasia.
    Logan YT; Belgeri MT
    Am J Geriatr Pharmacother; 2005 Jun; 3(2):103-14. PubMed ID: 16129387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis.
    Kim JH; Baek MJ; Sun HY; Lee B; Li S; Khandwala Y; Del Giudice F; Chung BI
    PLoS One; 2018; 13(10):e0203479. PubMed ID: 30281615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.
    Traish AM
    Adv Exp Med Biol; 2017; 1043():473-526. PubMed ID: 29224108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia.
    Hwang EC; Gandhi S; Jung JH; Imamura M; Kim MH; Pang R; Dahm P
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD007360. PubMed ID: 30306544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.